| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015329A1 Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus |
| 09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/16/1992 | EP0503710A2 Flunarizine containing anti-neoplastic compositions |
| 09/16/1992 | EP0358640B1 Dehydrating vesicule preparations for long-term storage |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/14/1992 | WO1992016276A1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS |
| 09/14/1992 | CA2104232A1 Process for purification of hmg-coa reductase inhibitors |
| 09/09/1992 | EP0227818B1 Antiglaucoma compositions |
| 09/09/1992 | CA2061891A1 Flunarizine containing anti-neoplastic compositions |
| 09/08/1992 | US5145686 Topical pharmaceutical compositions |
| 09/08/1992 | US5145685 Skin treatment method and composition |
| 09/08/1992 | US5145677 Process for treatment of diseases |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/05/1992 | WO1992015332A1 Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 09/05/1992 | CA2104684A1 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 09/03/1992 | WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 09/02/1992 | EP0501678A2 Treatment of ocular hypertension with a synergistic combination |
| 09/02/1992 | EP0501641A1 L-2-oxothiazolidine-4-carboxylate and glutathion esters for the treatment of hepatic diseases |
| 09/02/1992 | EP0501637A2 Use of L-2-oxothiazolidine-4-carboxylate alone or in combination with glutathione esters and/or amino acids in the treatment of reperfusion injury |
| 09/02/1992 | EP0500905A1 Pharmaceutical compositions for use in treating aids. |
| 09/02/1992 | EP0494974A4 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 09/02/1992 | EP0437488A4 Animal model for human disease |
| 09/02/1992 | EP0401243B1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
| 09/01/1992 | CA1306966C Human monocytes cultured in suspension in serum-free medium |
| 08/27/1992 | CA2061271A1 Method for the treatment of hepatic failure and disease |
| 08/26/1992 | WO1992014364A1 Opiate receptor antagonist modulates hyperkinetic movement disorder |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/25/1992 | US5141735 Viricides for AIDS treatment |
| 08/25/1992 | CA1306692C Penetration enhancers for transdermal delivery of systemic agents |
| 08/25/1992 | CA1306684C Stabilisation of mercury-containing preservatives in ophthalmic medicaments |
| 08/25/1992 | CA1306677C Composition for transdermal therapeutic systems of loop diuretics and a process for its preparation |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013565A1 Growth factor containing matrix for the treatment of cartilage lesions |
| 08/20/1992 | WO1992013564A1 Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | CA2058263A1 Pharmaceutical formulations |
| 08/19/1992 | EP0499142A2 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs |
| 08/19/1992 | EP0316434B1 Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 08/18/1992 | US5140012 Method for preventing onset of restenosis after angioplasty employing pravastatin |
| 08/13/1992 | DE4121389A1 Pharmazeutisches produkt zur behandlung von viruserkrankungen A pharmaceutical product for the treatment of viral diseases |
| 08/13/1992 | DE4121388A1 Pharmazeutisches produkt zur behandlung von viruserkrankungen A pharmaceutical product for the treatment of viral diseases |
| 08/12/1992 | EP0498471A2 Liposomes comprising a guanidino aminoglycoside |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498361A2 Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor |
| 08/12/1992 | EP0494256A4 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 08/11/1992 | US5137878 Composition and method for treatment of senile dementia |
| 08/10/1992 | CA2060954A1 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
| 08/10/1992 | CA2060937A1 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
| 08/08/1992 | WO1992013524A1 Pharmaceutical for treating viral diseases |
| 08/08/1992 | WO1992013523A1 Pharmaceutical product for treating viral diseases |
| 08/08/1992 | CA2079868A1 Pharmaceutical for treating viral diseases |
| 08/08/1992 | CA2079867A1 Pharmaceutical product for treating viral diseases |
| 08/06/1992 | WO1992011037A3 Targeting of therapeutic agents using polysaccharides |
| 08/05/1992 | EP0497516A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin II antagonists |
| 08/05/1992 | EP0497258A2 Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer |
| 08/04/1992 | US5135956 Fatty alcohol |
| 08/04/1992 | US5135933 Method for transplantation of fertilized ova |
| 08/04/1992 | US5135746 Control of protozoal disease |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 07/31/1992 | CA2060055A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin ii antagonists |
| 07/30/1992 | CA2060138A1 New use of the adenosine antagonist |
| 07/29/1992 | EP0308460B1 A composition for the topical treatment of glaucoma or ocular hypertension |
| 07/28/1992 | US5134168 Phenoxy and phenylthio, amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections |
| 07/28/1992 | CA1305668C Multivitamin preparation |
| 07/23/1992 | WO1992012165A1 METHODS FOR PREPARATION AND USE OF 1α,24-DIHYDROXY VITAMIN D¿2? |
| 07/23/1992 | WO1992011851A1 Method and compositions for treatment of sexual impotence |
| 07/22/1992 | EP0495349A2 Composition of an active agent for oral administration, especially to ruminants |
| 07/22/1992 | EP0495105A1 Inhibitor of absorption of digestion product of food and drink |
| 07/22/1992 | EP0494974A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 07/22/1992 | EP0413751A4 Neurologically active compounds |
| 07/21/1992 | US5132222 Established cell line, kml1-7, which produces b-cell differentiation factor (bcdf) |
| 07/21/1992 | US5132109 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof |
| 07/21/1992 | CA1305420C Pharmaceutical preparation having antihypertensive activity |
| 07/21/1992 | CA1305418C Transdermal delivery of pharmaceuticals |
| 07/15/1992 | EP0494405A2 Use of thiazolidine-4-carboxylate derivatives for the treatment of pulmonary diseases |
| 07/15/1992 | EP0494256A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 07/15/1992 | EP0494224A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 07/15/1992 | EP0340270B1 5-ht 3? receptor antagonists for treatment of cough and bronchoconstriction |
| 07/14/1992 | US5130132 Reducing addiction to nicotine |
| 07/14/1992 | CA1305054C2 Encapsulation of antineoplastic agents in liposomes |
| 07/14/1992 | CA1305053C Synthetic polymeric drugs |
| 07/11/1992 | CA2058793A1 Method for treatment for pulmonary disease |
| 07/09/1992 | WO1992011003A1 Pharmaceutical compositions |
| 07/08/1992 | EP0493485A1 Erection-inducing methods and compositions |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0485486A4 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 07/07/1992 | US5128341 Use of β-receptor blocking agents |
| 07/07/1992 | US5128126 Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions |
| 07/01/1992 | EP0493151A1 Slimming composition containing ginkgo biloba as alpha-2 blocker |
| 07/01/1992 | EP0492247A1 Effervescent H2 blocker formulation |
| 07/01/1992 | EP0491792A1 Methods of treating neurodegenerative conditions |
| 07/01/1992 | EP0256090B1 Solubilization of hydrophobic materials using lysophospholipid |
| 06/30/1992 | US5126342 Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| 06/30/1992 | CA1304295C Anesthetic composition and method of using the same |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |